Alexis cortot is a pulmonary onocologist at Lille University Hospital. His expertise encompasses human clinical research in lung cancer, targeted therapies, theranostic biomarkers in lung cancer, the biology of oncogene-addicted lung cancer, and the biological and clinical targeting of the MET receptor.
Alexis Cortot
- Wordpackage: Tackling emergent and hard-to-treat targets
- Institution: OncoLille, Lille
- Current position:
- Head of the Department of Thoracic Oncology, CHU Lille since 2020
- Professor, Pneumology, CHU Lille since 2014
- Investigator, CANTHER team, INSERM UMR-S1277 & CNRS UMR 9020, Lille University